通过药物重新定位,在产前症中准热囊细胞线粒体功能障碍
Dinara Afrose1, Sofía Alfonso-Sánchez2, Ashleigh Philp3
1School of Life Sciences, Faculty of Science, University of Technology Sydney, NSW, Australia.
Chemico-biological interactions
|December 17, 2025
概括
线粒体功能障碍有助于产前. 这项研究发现,阿司匹林,甲福明,白醇和AD-01通过改善预先怀孕的模型中的热囊细胞线粒体健康来显示治疗潜力.
科学领域:
- 生殖生物学 生殖生物学
- 线粒体生物学 线粒体生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 孕前是一种妊娠障碍,其特征是高血压和器官损伤.
- 线粒体功能障碍是孕前的一个关键因素,导致胎盘问题和氧化应激.
研究的目的:
- 为了研究 mitochondrial 功能障碍的机制在第一季度的 trofhoblast 细胞.
- 评估阿司匹林,甲福明,白醇和AD-01在改善热细胞线粒体健康方面的治疗潜力.
主要方法:
- 开发了一种2D体外模型,用于模拟产前症 (缺氧,线粒体功能障碍,炎症) 的第一三个月的热囊细胞.
- 在模仿孕前的刺激下,用甲福明,白醇,AD-01或阿司匹林治疗细胞.
- 使用免疫光,海马XF线粒应激试验和RT-qPCR对关键基因表达 (mfn1, dnm1l, atg5, map1lc3b) 进行线粒体动态评估.
主要成果:
- 孕前的刺激显著改变了线粒体网络,减少了大小和数量,同时增加了循环性.
- 甲胺在炎症下改善了线粒体结构,并使关键基因表达和生物能学正常化.
- 亚司匹林在缺氧下增强了线粒体形态;复星和AD-01表明了取决于环境的保护作用.
结论:
- 缺氧,炎症和线粒体功能障碍是孕前病理学的关键因素.
- 阿司匹林,甲福明,白醇和AD-01代表了改善子宫前症中线粒体健康的有希望的治疗策略.
- 有针对性的干预措施可以增强线粒体功能,并改善孕前妇女的妊娠结果.
相关概念视频
01:46Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
01:07Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
01:26Targets for Drug Action: Overview
9.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K